Skip to main content
PMC home page
Antibodies logoLink to Antibodies
. 2018 Aug 30;7(3):34. doi: 10.3390/antib7030034

Correction: Verkade, J.M.M.; et al. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7, 12

Jorge M M Verkade 1, Marloes A Wijdeven 1, Remon van Geel 1, Brian M G Janssen 1, Sander S van Berkel 1, Floris L van Delft 1; Antibodies Editorial Office2,*
PMCID: PMC6640684  PMID: 31544884

The conflict of interest section of the published paper [1] has been updated as follows:

“All authors are employees of Synaffix BV, whose product HydraSpace was introduced in this paper.”

The manuscript will be updated and the original will remain online on the article webpage.

Reference

  • 1.Verkade J.M.M., Wijdeven M.A., van Geel R., Janssen B.M.G., van Berkel S.S., van Delft F.L. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies. 2018;7:12. doi: 10.3390/antib7010012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antibodies are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES